Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

AB SCIEX Academic Partnership Program Funds University of Texas Southwestern Researcher

Published: Wednesday, November 14, 2012
Last Updated: Wednesday, November 14, 2012
Bookmark and Share
AB SCIEX is supporting the lipidomics research of Jeff McDonald, Ph.D., an associate professor in the Department of Molecular Genetics at the University of Texas Southwestern Medical Center.

This is the first grant awarded to an academic researcher as part of the AB SCIEX Academic Partnership Program,  which was launched earlier this year. This grant aims to help Dr. McDonald accelerate advancements toward the realization of personalized medicine.

AB SCIEX selected Dr. McDonald as the program’s first grant winner because of the breakthrough work he is doing to advance lipidomics and metabolomics. Dr. McDonald is a leader in the field of lipidomics, and his work includes directing the mass spectrometry branch of the LIPID MAPS Sterol Core where they recently concluded a sterolomic analysis of the Dallas Heart Study, a 3200+ human subject cohort.

Dr. McDonald has ongoing collaborations with Phil Sanders, a senior research scientist at a leading pharmaceutical company, who pioneered direct infusion techniques using the TripleTOF 5600 platform, which will be the basis for the work at UT Southwestern. With access to extensive collections of biological samples at UT Southwestern, this academic researcher sees an opportunity for significant discoveries. Ultimately, lipidomic and metabolomic analysis of human samples will elucidate new understanding of disease states that will help in the development of treatments of metabolic diseases, such as obesity, hypertension and diabetes.

Prior to the grant from AB SCIEX, the team at UT was limited in what they could achieve in infusion-based lipidomics research and unable to apply the workflows that Sanders had developed. Funding to acquire the instrument had been a major challenge for Dr. McDonald and his team, who have been focused on lipidomics for the past eight years. The answer was AB SCIEX’s program for academics.

“The AB SCIEX Academic Partnership program cleared the way for us to bring on campus the TripleTOF 5600+ system, which is exactly the technology needed by the lipid field to advance the study of lipidomics,” said Jeff McDonald, Associate Professor at the University of Texas Southwestern Medical Center in Dallas. “AB SCIEX instrumentation is second to none, especially the Turbo V ion source, which is tough as nails and allows us to do things that simply cannot be done on other instruments. We wouldn’t have the latest innovations in mass spectrometry at UT Southwestern if not for the company’s academic partnership program. We appreciate and value AB SCIEX’s support for academic research.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIEX and Hepregen Announce Co-Marketing Agreement
Alliance establishes SCIEX and Hepregen as a one-stop solution provider for drug metabolism investigators.
Friday, May 22, 2015
Sciex, Hepregen Team up on Metabolite Identification Offering
This recently announced collaboration aims to provide practical solutions for drug metabolism researchers.
Thursday, May 21, 2015
SCIEX and Mass Consortium Corporation Announce Exclusive Reseller Agreement
SCIEX to provide customers with XCMSplus software solution for simplified and accelerated metabolomics workflows.
Tuesday, March 31, 2015
AB SCIEX Wins New Product Innovation Award in Asia Pacific
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.
Thursday, October 30, 2014
Barry Karger Receives Arnold O. Beckman Award
Award honors Prof Karger for his outstanding achievements in the field of electrodriven separation techniques.
Monday, April 28, 2014
Researchers Solve a Mystery about Type 2 Diabetes Drug
AB SCIEX TripleTOF® and QTRAP® technologies support breakthrough medical study.
Friday, November 22, 2013
AB SCIEX Expands Support in the Middle East
AB SCIEX announces the opening of a new regional office and technical support centre located in Dubai.
Tuesday, October 29, 2013
AB SCIEX Receives Frost & Sullivan Award
AB SCIEX has been awarded the 2013 Global Market Share Leadership Award for Mass Spectrometry from Frost & Sullivan.
Thursday, September 12, 2013
AB SCIEX and LECO Announces Co-marketing Agreement
Bundled solutions leverage the synergy between two technology leaders.
Thursday, July 04, 2013
AB SCIEX and UOW to Collaborate
A research partnership between AB SCIEX and the University of Wollongong will develop lipid analysis capabilities, including the most definitive and comprehensive identification of double bond position in lipids.
Friday, September 21, 2012
AB Sciex Agrees for Sigma-Aldrich® to Distribute iChemistry™ Solutions
Broadens availability of mass spectrometry-based tagging chemistries to biologists and chemists worldwide.
Wednesday, September 12, 2012
AB SCIEX and Premier Biosoft Collaborate on Lipidomics Software
PREMIER Biosoft and AB SCIEX collaborate by offering data analysis solutions for lipidomics.
Monday, June 04, 2012
AB SCIEX Announces Academic Partnership Program
The program aims to increase the number of scientists who benefit from the company’s assistance and resources for advancing research in proteomics, metabolomics and lipidomics.
Wednesday, April 04, 2012
AB SCIEX Announces Academic Partnership Program to Support Biological Research
Focus on proteomics, metabolomics and lipidomics to accelerate promising work in science and biomedical studies.
Wednesday, March 28, 2012
AB SCIEX Expands Commercial Operations in Brazil
The expansion will support the increasing use of mass spectrometry for food safety testing, environmental analysis, academic research, drug development, forensic toxicology and clinical research.
Monday, March 19, 2012
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Antioxidants Cause Malignant Melanoma to Metastasize Faster
Fresh research at Sahlgrenska Academy has found that antioxidants can double the rate of melanoma metastasis in mice.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos